SEC Form 4 · accession 0001140361-16-087654
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Oct 7, 2016
Accepted (ET)
Nov 22, 2016 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 7, 2016 | G | 360 | $0.00 | D | 70,798 | D | |
| Common StockF2 | Nov 18, 2016 | M | 5,000 | $38.59 | A | 75,798 | D | |
| Common StockF2,F3 | Nov 18, 2016 | S | 5,000 | $90.42 | D | 70,798 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Common StockF2,F4 | $38.59 | Nov 18, 2016 | M | 5,000 | D | Nov 22, 2008 | May 21, 2018 | Common Stock | 5,000 | 42,344 | D |
Explanation of responses
- F1On October 7, 2016, the reporting person gifted 360 shares to an educational institution.
- F2Transaction made pursuant to a 10b5-1 trading plan executed on November 2, 2016.
- F3All shares were sold at the same price.
- F4Reflects the number of stock options outstanding after the transaction from this specific stock option grant.